Virtu Financial LLC Selecta Biosciences Inc Transaction History

Virtu Financial LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$0.67 - $1.35 $59,417 - $119,722	88,683 New	88,683 $61,000
Q2 2023 Jul 27, 2023	BUY	$1.04 - $1.4 $57,989 - $78,062	55,759 New	55,759 $62,000
Q3 2022 Nov 07, 2022	BUY	$1.33 - $2.6 $30,490 - $59,605	22,925 New	22,925 $38,000
Q1 2022 May 17, 2022	SELL	$1.23 - $3.31 $69,285 - $186,452	-56,330 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$2.89 - $4.43 $18,175 - $27,860	6,289 Added 12.57%	56,330 $184,000
Q3 2021 Nov 12, 2021	SELL	$3.36 - $4.62 $26,470 - $36,396	-7,878 Reduced 13.6%	50,041 $208,000
Q2 2021 Sep 17, 2021	BUY	$2.82 - $5.01 $163,331 - $290,174	57,919 New	57,919 $242,000
Q1 2021 May 19, 2021	SELL	$2.92 - $5.07 $39,662 - $68,865	-13,583 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$1.64 - $3.42 $1,669 - $3,481	1,018 Added 8.1%	13,583 $41,000
Q3 2020 Dec 11, 2020	SELL	$2.18 - $2.84 $31,171 - $40,609	-14,299 Reduced 53.23%	12,565 $31,000
Q2 2020 Aug 07, 2020	BUY	$1.83 - $4.06 $6,436 - $14,279	3,517 Added 15.06%	26,864 $76,000
Q3 2018 Nov 13, 2018	BUY	$12.07 - $16.0 $281,798 - $373,552	23,347 New	23,347 $363,000
Q1 2018 May 14, 2018	SELL	$8.49 - $11.82 $264,879 - $368,772	-31,199 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$8.97 - $23.38 $279,855 - $729,432	31,199	31,199 $306,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.